IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

CPhI: DSM Sinochem Pharmaceuticals to build Atorvastatin facility in India

5:41 AM MDT | October 15, 2012 | Deepti Ramesh in Madrid

DSM Sinochem Pharmaceuticals (DSP; Singapore), the former DSM Anti-Infectives business, says that it is planning to build production capacity for manufacturing the active pharmaceutical ingredient (API) for atorvastatin, the generic version of cholesterol-lowering drug Lipitor, at DSP’s existing production facility at Toansa, India. Pfizer’s Lipitor has been the top-selling drug worldwide. DSP says it is also considering manufacturing the finished dosage form of atorvastatin. “[Atorvastatin] will be an important business for the company and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa